Barry Boatman

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
582 Background: LBH589 is a novel histone deacetylase inhibitor (HDACi) which induces apoptosis of tumor cells. LBH589 has been shown to cause regression of colon cancer in animal models and phase I trials have shown the agent to be well tolerated, providing rationale for studying this agent in pts with MCRC. METHODS This was a multicenter, open-label(More)
  • 1